Stroke
May 15, 2008
Neurobiological Technologies, Inc. Presents Dosing Rationale For...
“The prior studies of Viprinex showed improved efficacy, but used a dosing regimen that infused the drug over five to seven days, which kept fibrinogen levels low for too long, compromising safety”
Main Category: Stroke / Neuroprotection Also Included In: Pharma Industry / Biotech Industry Neurobiological Technologies, Inc. via MediLexicon
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Beijing Air May Cause Heart Attacks | 15 hr | Larry | 6 |
| Beijing Air May Cause Heart Attacks - Health Ne... | Wed | Lincoln Charles | 1 |
| Sen. Edward M. Kennedy hospitalized with sympto... | Jul 15 | Steve | 53 |
| Disorder hikes risk of clots | Jun 25 | fayzee | 1 |
| Rising Health Costs Sending Americans to China ... | Jun 24 | Tex | 1 |
| hurrah. my book is published!! | Jun '08 | sakima | 1 |
| PAD a source of discomfort -- Health Treatments | Jun '08 | Rosemary Wil... | 2 |
Most Popular
